323 related articles for article (PubMed ID: 24305518)
21. Measuring the efficacy of antihypertensive therapy by ambulatory blood pressure monitoring in the primary care setting.
White WB; Giles T; Bakris GL; Neutel JM; Davidai G; Weber MA
Am Heart J; 2006 Jan; 151(1):176-84. PubMed ID: 16368314
[TBL] [Abstract][Full Text] [Related]
22. Early combination therapy with telmisartan plus amlodipine for rapid achievement of blood pressure goals.
Neldam S; Dahlöf B; Oigman W; Schumacher H
Int J Clin Pract; 2013 Sep; 67(9):843-52. PubMed ID: 23952464
[TBL] [Abstract][Full Text] [Related]
23. Beneficial cardiometabolic actions of telmisartan plus amlodipine therapy in elderly patients with poorly controlled hypertension.
Bekki H; Yamamoto K; Sone M; Homma T; Nakata M; Nohara M; Fukami K; Okuda S; Yamagishi S
Clin Cardiol; 2011 Apr; 34(4):261-5. PubMed ID: 21432858
[TBL] [Abstract][Full Text] [Related]
24. Effect of telmisartan vs. ramipril on 'dipping' status and blood pressure variability: pooled analysis of the PRISMA studies.
Gosse P; Schumacher H
Hypertens Res; 2014 Feb; 37(2):151-7. PubMed ID: 24048485
[TBL] [Abstract][Full Text] [Related]
25. Long-term safety and efficacy of telmisartan/amlodipine single pill combination in the treatment of hypertension.
Billecke SS; Marcovitz PA
Vasc Health Risk Manag; 2013; 9():95-104. PubMed ID: 23662062
[TBL] [Abstract][Full Text] [Related]
26. Telmisartan 80 mg/hydrochlorothiazide 25 mg provides clinically relevant blood pressure reductions across baseline blood pressures.
Neldam S; Schumacher H; Guthrie R
Adv Ther; 2012 Apr; 29(4):327-38. PubMed ID: 22477543
[TBL] [Abstract][Full Text] [Related]
27. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
Lacourcière Y; Neutel JM; Schumacher H
Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
[TBL] [Abstract][Full Text] [Related]
28. Telmisartan/amlodipine: single-pill combination in hypertension.
Moen MD
Am J Cardiovasc Drugs; 2010; 10(6):401-12. PubMed ID: 21090832
[TBL] [Abstract][Full Text] [Related]
29. Combination of telmisartan plus amlodipine in the treatment of hypertension: review of results.
Oigman W; Neves MF; Gismondi RA
Expert Rev Cardiovasc Ther; 2010 Nov; 8(11):1509-17. PubMed ID: 21090924
[TBL] [Abstract][Full Text] [Related]
30. Indapamide SR versus candesartan and amlodipine in hypertension: the X-CELLENT Study.
London G; Schmieder R; Calvo C; Asmar R
Am J Hypertens; 2006 Jan; 19(1):113-21. PubMed ID: 16461202
[TBL] [Abstract][Full Text] [Related]
31. Effect of tablets with a combination of telmisartan and amlodipine on patients with hypertension: the Cotalo study.
Ohishi M; Kawai T; Hayashi N; Kitano S; Katsuya T; Nagano M; Hirotani A; Yamamoto K; Kamide K; Rakugi H
Hypertens Res; 2013 Jul; 36(7):620-6. PubMed ID: 23425955
[TBL] [Abstract][Full Text] [Related]
32. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
Shimada K; Ogihara T; Saruta T; Kuramoto K;
Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
[TBL] [Abstract][Full Text] [Related]
33. Review: a single-pill combination of telmisartan plus amlodipine for the treatment of hypertension.
Guthrie RM
Postgrad Med; 2011 Nov; 123(6):58-65. PubMed ID: 22104454
[TBL] [Abstract][Full Text] [Related]
34. Ambulatory blood pressure monitoring in the primary care setting: assessment of therapy on the circadian variation of blood pressure from the MICCAT-2 Trial.
White WB; Weber MA; Davidai G; Neutel JM; Bakris GL; Giles T
Blood Press Monit; 2005 Jun; 10(3):157-63. PubMed ID: 15923818
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and duration of action of the four selective angiotensin II subtype 1 receptor blockers, losartan, candesartan, valsartan and telmisartan, in patients with essential hypertension determined by home blood pressure measurements.
Nishimura T; Hashimoto J; Ohkubo T; Kikuya M; Metoki H; Asayama K; Totsune K; Imai Y
Clin Exp Hypertens; 2005 Aug; 27(6):477-89. PubMed ID: 16081340
[TBL] [Abstract][Full Text] [Related]
36. Antihypertensive efficacy of telmisartan vs ramipril over the 24-h dosing period, including the critical early morning hours: a pooled analysis of the PRISMA I and II randomized trials.
Williams B; Lacourcière Y; Schumacher H; Gosse P; Neutel JM
J Hum Hypertens; 2009 Sep; 23(9):610-9. PubMed ID: 19225530
[TBL] [Abstract][Full Text] [Related]
37. Blood pressure control by the nifedipine GITS-telmisartan combination in patients at high cardiovascular risk: the TALENT study.
Mancia G; Parati G; Bilo G; Choi J; Kilama MO; Ruilope LM;
J Hypertens; 2011 Mar; 29(3):600-9. PubMed ID: 21252701
[TBL] [Abstract][Full Text] [Related]
38. Importance of a fixed combination of telmisartan and amlodipine for the treatment of hypertension.
Ahrens K; Bramlage P
Drugs Today (Barc); 2010 May; 46(5):339-50. PubMed ID: 20517535
[TBL] [Abstract][Full Text] [Related]
39. Chronotherapy with valsartan/amlodipine fixed combination: improved blood pressure control of essential hypertension with bedtime dosing.
Hermida RC; Ayala DE; Fontao MJ; Mojón A; Fernández JR
Chronobiol Int; 2010 Jul; 27(6):1287-303. PubMed ID: 20653455
[TBL] [Abstract][Full Text] [Related]
40. Effect of telmisartan/hydrochlorothiazide combination versus nifedipine GITS on ambulatory blood pressure and sympathetic activation.
Fogari R; Preti P; Zoppi A; Corradi L; Pasotti C; Rinaldi A; Mugellini A
Am J Hypertens; 2005 May; 18(5 Pt 1):577-83. PubMed ID: 15882537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
